aluates Reports

$ 0.0

Automative

Global Cancer Oncology Testing Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-13B13808

Global Cancer Oncology Testing Market Research Report 2023

BUY CHAPTERS

Global Cancer Oncology Testing Market Research Report 2025

Code: QYRE-Auto-13B13808

Report

April 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Personal Genome Diagnostics

Veracyte, Inc.

Pacific Biosciences of California

Qiagen NV

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

Illumina Inc

Agendia

Devyser

Cancer Oncology Testing Market

The global market for Cancer Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cancer Oncology Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Oncology Testing.

The Cancer Oncology Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Oncology Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Oncology Testing Market Report

Report Metric	Details
Report Name	Cancer Oncology Testing Market
Segment by Type	Fluorescence In Situ Hybridization Polymerase Chain Reaction Microarray Technology Serum Proteomics Nucleic Acid Sequencing
Segment by Application	Hospitals Speciality Clinics Research Institutes Diagnostics Laboratories Biopharmaceutical Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Oncology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Oncology Testing Market report?

Ans: The main players in the Cancer Oncology Testing Market are Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics

What are the Application segmentation covered in the Cancer Oncology Testing Market report?

Ans: The Applications covered in the Cancer Oncology Testing Market report are Hospitals, Speciality Clinics, Research Institutes, Diagnostics Laboratories, Biopharmaceutical Companies

What are the Type segmentation covered in the Cancer Oncology Testing Market report?

Ans: The Types covered in the Cancer Oncology Testing Market report are Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Microarray Technology, Serum Proteomics, Nucleic Acid Sequencing

Recommended Reports

Oncology Diagnostics

Cancer Therapeutics

Cancer Screening Kits

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Oncology Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Fluorescence In Situ Hybridization

1.2.3 Polymerase Chain Reaction

1.2.4 Microarray Technology

1.2.5 Serum Proteomics

1.2.6 Nucleic Acid Sequencing

1.3 Market by Application

1.3.1 Global Cancer Oncology Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Speciality Clinics

1.3.4 Research Institutes

1.3.5 Diagnostics Laboratories

1.3.6 Biopharmaceutical Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Oncology Testing Market Perspective (2020-2031)

2.2 Global Cancer Oncology Testing Growth Trends by Region

2.2.1 Global Cancer Oncology Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Oncology Testing Historic Market Size by Region (2020-2025)

2.2.3 Cancer Oncology Testing Forecasted Market Size by Region (2026-2031)

2.3 Cancer Oncology Testing Market Dynamics

2.3.1 Cancer Oncology Testing Industry Trends

2.3.2 Cancer Oncology Testing Market Drivers

2.3.3 Cancer Oncology Testing Market Challenges

2.3.4 Cancer Oncology Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Oncology Testing Players by Revenue

3.1.1 Global Top Cancer Oncology Testing Players by Revenue (2020-2025)

3.1.2 Global Cancer Oncology Testing Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Oncology Testing Revenue

3.4 Global Cancer Oncology Testing Market Concentration Ratio

3.4.1 Global Cancer Oncology Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Oncology Testing Revenue in 2024

3.5 Global Key Players of Cancer Oncology Testing Head office and Area Served

3.6 Global Key Players of Cancer Oncology Testing, Product and Application

3.7 Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Oncology Testing Breakdown Data by Type

4.1 Global Cancer Oncology Testing Historic Market Size by Type (2020-2025)

4.2 Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031)

5 Cancer Oncology Testing Breakdown Data by Application

5.1 Global Cancer Oncology Testing Historic Market Size by Application (2020-2025)

5.2 Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Oncology Testing Market Size (2020-2031)

6.2 North America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Oncology Testing Market Size by Country (2020-2025)

6.4 North America Cancer Oncology Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Oncology Testing Market Size (2020-2031)

7.2 Europe Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Oncology Testing Market Size by Country (2020-2025)

7.4 Europe Cancer Oncology Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Oncology Testing Market Size (2020-2031)

8.2 Asia-Pacific Cancer Oncology Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Oncology Testing Market Size (2020-2031)

9.2 Latin America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Oncology Testing Market Size by Country (2020-2025)

9.4 Latin America Cancer Oncology Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Oncology Testing Market Size (2020-2031)

10.2 Middle East & Africa Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Devyser

11.1.1 Devyser Company Details

11.1.2 Devyser Business Overview

11.1.3 Devyser Cancer Oncology Testing Introduction

11.1.4 Devyser Revenue in Cancer Oncology Testing Business (2020-2025)

11.1.5 Devyser Recent Development

11.2 Agendia

11.2.1 Agendia Company Details

11.2.2 Agendia Business Overview

11.2.3 Agendia Cancer Oncology Testing Introduction

11.2.4 Agendia Revenue in Cancer Oncology Testing Business (2020-2025)

11.2.5 Agendia Recent Development

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Cancer Oncology Testing Introduction

11.3.4 Illumina Revenue in Cancer Oncology Testing Business (2020-2025)

11.3.5 Illumina Recent Development

11.4 Personal Genome Diagnostics

11.4.1 Personal Genome Diagnostics Company Details

11.4.2 Personal Genome Diagnostics Business Overview

11.4.3 Personal Genome Diagnostics Cancer Oncology Testing Introduction

11.4.4 Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025)

11.4.5 Personal Genome Diagnostics Recent Development

11.5 Veracyte

11.5.1 Veracyte Company Details

11.5.2 Veracyte Business Overview

11.5.3 Veracyte Cancer Oncology Testing Introduction

11.5.4 Veracyte Revenue in Cancer Oncology Testing Business (2020-2025)

11.5.5 Veracyte Recent Development

11.6 Pacific Biosciences of California

11.6.1 Pacific Biosciences of California Company Details

11.6.2 Pacific Biosciences of California Business Overview

11.6.3 Pacific Biosciences of California Cancer Oncology Testing Introduction

11.6.4 Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025)

11.6.5 Pacific Biosciences of California Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Cancer Oncology Testing Introduction

11.7.4 Qiagen Revenue in Cancer Oncology Testing Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 Agilent Technologies

11.8.1 Agilent Technologies Company Details

11.8.2 Agilent Technologies Business Overview

11.8.3 Agilent Technologies Cancer Oncology Testing Introduction

11.8.4 Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025)

11.8.5 Agilent Technologies Recent Development

11.9 Natera

11.9.1 Natera Company Details

11.9.2 Natera Business Overview

11.9.3 Natera Cancer Oncology Testing Introduction

11.9.4 Natera Revenue in Cancer Oncology Testing Business (2020-2025)

11.9.5 Natera Recent Development

11.10 Bio Rad Laboratories

11.10.1 Bio Rad Laboratories Company Details

11.10.2 Bio Rad Laboratories Business Overview

11.10.3 Bio Rad Laboratories Cancer Oncology Testing Introduction

11.10.4 Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025)

11.10.5 Bio Rad Laboratories Recent Development

11.11 Myriad Genetics

11.11.1 Myriad Genetics Company Details

11.11.2 Myriad Genetics Business Overview

11.11.3 Myriad Genetics Cancer Oncology Testing Introduction

11.11.4 Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025)

11.11.5 Myriad Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Personal Genome Diagnostics

Veracyte, Inc.

Pacific Biosciences of California

Qiagen NV

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

Illumina Inc

Agendia

Devyser

List of Tables

Table 1. Global Cancer Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Fluorescence In Situ Hybridization

Table 3. Key Players of Polymerase Chain Reaction

Table 4. Key Players of Microarray Technology

Table 5. Key Players of Serum Proteomics

Table 6. Key Players of Nucleic Acid Sequencing

Table 7. Global Cancer Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cancer Oncology Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Cancer Oncology Testing Market Share by Region (2020-2025)

Table 11. Global Cancer Oncology Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Cancer Oncology Testing Market Share by Region (2026-2031)

Table 13. Cancer Oncology Testing Market Trends

Table 14. Cancer Oncology Testing Market Drivers

Table 15. Cancer Oncology Testing Market Challenges

Table 16. Cancer Oncology Testing Market Restraints

Table 17. Global Cancer Oncology Testing Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Cancer Oncology Testing Market Share by Players (2020-2025)

Table 19. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)

Table 20. Ranking of Global Top Cancer Oncology Testing Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Cancer Oncology Testing Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Cancer Oncology Testing, Headquarters and Area Served

Table 23. Global Key Players of Cancer Oncology Testing, Product and Application

Table 24. Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cancer Oncology Testing Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Cancer Oncology Testing Revenue Market Share by Type (2020-2025)

Table 28. Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Cancer Oncology Testing Revenue Market Share by Type (2026-2031)

Table 30. Global Cancer Oncology Testing Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Cancer Oncology Testing Revenue Market Share by Application (2020-2025)

Table 32. Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Cancer Oncology Testing Revenue Market Share by Application (2026-2031)

Table 34. North America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Cancer Oncology Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)

Table 49. Devyser Company Details

Table 50. Devyser Business Overview

Table 51. Devyser Cancer Oncology Testing Product

Table 52. Devyser Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 53. Devyser Recent Development

Table 54. Agendia Company Details

Table 55. Agendia Business Overview

Table 56. Agendia Cancer Oncology Testing Product

Table 57. Agendia Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 58. Agendia Recent Development

Table 59. Illumina Company Details

Table 60. Illumina Business Overview

Table 61. Illumina Cancer Oncology Testing Product

Table 62. Illumina Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 63. Illumina Recent Development

Table 64. Personal Genome Diagnostics Company Details

Table 65. Personal Genome Diagnostics Business Overview

Table 66. Personal Genome Diagnostics Cancer Oncology Testing Product

Table 67. Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 68. Personal Genome Diagnostics Recent Development

Table 69. Veracyte Company Details

Table 70. Veracyte Business Overview

Table 71. Veracyte Cancer Oncology Testing Product

Table 72. Veracyte Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 73. Veracyte Recent Development

Table 74. Pacific Biosciences of California Company Details

Table 75. Pacific Biosciences of California Business Overview

Table 76. Pacific Biosciences of California Cancer Oncology Testing Product

Table 77. Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 78. Pacific Biosciences of California Recent Development

Table 79. Qiagen Company Details

Table 80. Qiagen Business Overview

Table 81. Qiagen Cancer Oncology Testing Product

Table 82. Qiagen Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 83. Qiagen Recent Development

Table 84. Agilent Technologies Company Details

Table 85. Agilent Technologies Business Overview

Table 86. Agilent Technologies Cancer Oncology Testing Product

Table 87. Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 88. Agilent Technologies Recent Development

Table 89. Natera Company Details

Table 90. Natera Business Overview

Table 91. Natera Cancer Oncology Testing Product

Table 92. Natera Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 93. Natera Recent Development

Table 94. Bio Rad Laboratories Company Details

Table 95. Bio Rad Laboratories Business Overview

Table 96. Bio Rad Laboratories Cancer Oncology Testing Product

Table 97. Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 98. Bio Rad Laboratories Recent Development

Table 99. Myriad Genetics Company Details

Table 100. Myriad Genetics Business Overview

Table 101. Myriad Genetics Cancer Oncology Testing Product

Table 102. Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)

Table 103. Myriad Genetics Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

Table 107. Authors List of This Report

List of Figures

Figure 1. Cancer Oncology Testing Picture

Figure 2. Global Cancer Oncology Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Oncology Testing Market Share by Type: 2024 VS 2031

Figure 4. Fluorescence In Situ Hybridization Features

Figure 5. Polymerase Chain Reaction Features

Figure 6. Microarray Technology Features

Figure 7. Serum Proteomics Features

Figure 8. Nucleic Acid Sequencing Features

Figure 9. Global Cancer Oncology Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Cancer Oncology Testing Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Speciality Clinics Case Studies

Figure 13. Research Institutes Case Studies

Figure 14. Diagnostics Laboratories Case Studies

Figure 15. Biopharmaceutical Companies Case Studies

Figure 16. Cancer Oncology Testing Report Years Considered

Figure 17. Global Cancer Oncology Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Cancer Oncology Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Cancer Oncology Testing Market Share by Region: 2024 VS 2031

Figure 20. Global Cancer Oncology Testing Market Share by Players in 2024

Figure 21. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Cancer Oncology Testing Revenue in 2024

Figure 23. North America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Cancer Oncology Testing Market Share by Country (2020-2031)

Figure 25. United States Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Cancer Oncology Testing Market Share by Country (2020-2031)

Figure 29. Germany Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Cancer Oncology Testing Market Share by Region (2020-2031)

Figure 37. China Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Cancer Oncology Testing Market Share by Country (2020-2031)

Figure 45. Mexico Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Cancer Oncology Testing Market Share by Country (2020-2031)

Figure 49. Turkey Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Devyser Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 53. Agendia Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 54. Illumina Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 55. Personal Genome Diagnostics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 56. Veracyte Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 57. Pacific Biosciences of California Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 58. Qiagen Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 60. Natera Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 61. Bio Rad Laboratories Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 62. Myriad Genetics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Genomic Testing in Cancer Market Research Report 2024

Oncology Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Global Tumor Biomarker Test Market Research Report 2024

Global Cancer Screening Technology Market Research Report 2024

Global Lymph Cancer Testing Market Research Report 2024

Global Cancer Insurance Market Research Report 2024

Global Lung Cancer Genomic Testing Market Research Report 2024

Global Antibodies in Oncology Market Research Report 2024

Global Oncology Companion Diagnostic Market Research Report 2024

Global Personalized Medicines In Oncology Market Research Report 2024

Global Lung Cancer Test Kit Market Research Report 2024

Circulating Tumor Cell Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Next Generation Oncology Devices Market Research Report 2024

Global Oncology Clinical Trial Monitor Market Research Report 2024

Global Cancer Cell Media Market Research Report 2024

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Informatics Market Research Report 2024

Global In Vitro Cancer Screening Tests Kits Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions